IDS participates in UAE Reproductive Symposium 2015

IDS sponsors the event with its Infertility product range Profertil

Dubai, February 24 2015:  Al Ittihad Drug Store (IDS), one of the leading pharmaceutical distributors in the UAE, is the Bronze sponsor for the upcoming UAE Reproductive Symposium 2015 scheduled for February 25-26, 2015. The high-quality CME symposium is organized by Fakih IVF in line with HH Sheikh Mohammed’s vision of making Dubai a center of medical excellence.  The aim of the event is to share the latest advances in reproductive medicine with new techniques and treatment modalities with other physicians in the UAE so that they can apply this knowledge in their practice and are able to offer better services to the patients. This symposium has been accredited by Dubai Health Authority.
IDS is one of the key sponsors for the Symposium with its product Profertil. IDS represents Profertil, an infertility product backed up with many published clinical studies on its formula, which makes Profertil a completely reliable and superior product in the market. 

Speaking on the participation announcement, Dalya Tabari, Director, IDS, said, “We are extremely pleased to be part of the UAE Reproductive Symposium 2015. At IDS, we are well versed with the subject of Infertility because of our product offering Profertil. Infertility is a very sensitive topic and it is important to increase the knowledge on other alternative infertility treatment. In a study conducted by Mayo Foundation for Medical Education and Research published in June 2007, out of all GCC countries UAE ranks second highest on infertility cases with a total of 100,446 cases in UAE alone. The increase in infertility rate globally is due to marriage at a late age and other unhealthy habits. Hence Symposiums like these make it imperative for better understanding and development of the medical industry in UAE.”  

The spokesperson added, “Profertil is a rich patented formula medicine that comes in 2 different products for male and female infertility problems. This Symposium will help act as a platform for IDS wherein our medical team will inform the doctors about the benefits of Profertil and act as a solution provider by helping the patients getting positive results.”